ASCO 2016: Novel antibody helps patients with advanced gastric cancer live longer
Findings from a European phase II study showed that the novel, first-in- class antibody IMAB362…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ASCO 2016: Antibody drug conjugate shows early promise in small cell lung cancer
Early findings from a first-in-human clinical trial showed that antibody drug conjugate (ADC) rovalpituzumab tesirine…
ASCO 2016: Precision medicine approach may expand therapeutic options for patients
Researchers reported encouraging early results from a phase II trial that matches patients with molecular…
Why we’re long overdue for a global standard in colorectal cancer care
By Julien Wiggins – Bowel Cancer Australia. Health professionals are gathering more data on colorectal cancer…
How Australians Die: cause #2 – cancers
By Terry Slevin, Cancer Council Australia and Andrew Redfern, University of Western Australia. Described as…
ASCO 2016: New Treatment for Advanced Breast Cancer Doubles Progression Free Survival Rates
New practice changing clinical trial results show that for postmenopausal women with advanced or metastatic…
New Zealand backs plain packaging for cigarettes
New Zealand said on Tuesday it will introduce plain packaging on tobacco products, joining a…
A combined approach to treating metastatic melanoma
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic…
Telstra Health will hold Australians’ cancer details, so we need to ensure their privacy is protected
By Stephen Duckett, Grattan Institute – The Conversation. The Department of Health recently announced that Telstra had…
Vitamin A may help improve pancreatic cancer chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy…